QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

NCT06951997 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: QL1706
DRUG: Chidamide
DRUG: Gemcitabine
DRUG: Nab-paclitaxel

Sponsor

Tianjin Medical University Cancer Institute and Hospital